Cubist Systematic Strategies, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 145 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,812,893
-45.2%
82,907
-31.5%
0.03%
-39.1%
Q2 2023$6,955,364
+209.3%
121,026
+101.8%
0.05%
+228.6%
Q1 2023$2,249,032
+475.0%
59,974
+329.6%
0.01%
+600.0%
Q4 2022$391,159
-56.9%
13,960
-56.8%
0.00%
-60.0%
Q3 2022$908,000
-76.7%
32,330
-71.2%
0.01%
-79.2%
Q2 2022$3,902,000
-22.5%
112,157
-20.0%
0.02%
-42.9%
Q1 2022$5,034,000
+461.2%
140,229
+264.1%
0.04%
+366.7%
Q4 2021$897,000
+222.7%
38,509
+163.7%
0.01%
+125.0%
Q3 2021$278,000
-32.4%
14,604
-28.3%
0.00%
-20.0%
Q2 2021$411,000
+49.5%
20,363
+35.7%
0.01%
+25.0%
Q1 2021$275,000
-70.1%
15,006
-63.4%
0.00%
-75.0%
Q2 2020$921,000
+328.4%
41,009
+183.2%
0.02%
+166.7%
Q1 2020$215,000
+8.6%
14,482
+41.1%
0.01%
+50.0%
Q4 2019$198,000
-77.0%
10,264
-76.4%
0.00%
-76.5%
Q3 2019$862,000
+26.0%
43,457
+34.1%
0.02%
+30.8%
Q2 2019$684,000
+183.8%
32,405
+167.7%
0.01%
+18.2%
Q4 2018$241,000
-18.3%
12,105
-37.4%
0.01%
-26.7%
Q2 2018$295,000
+1240.9%
19,324
+1620.7%
0.02%
+1400.0%
Q4 2017$22,000
+1000.0%
1,123
+1190.8%
0.00%
Q2 2017$2,000
-98.8%
87
-99.4%
0.00%
-100.0%
Q4 2014$163,00014,0730.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders